FWS steps ahead of previous methods of detection of minute temperature variations in the breast by analyzing discrete dynamic thermal finger print data points. Bioinformatics software analysis compares the finger print profile with the FWS database with completed cases having temperature registration, mammographic findings, and biopsy results.

The FWS demonstrates that the use of multiple interpretive systems can bring its capabilities within 90% specificity and sensitivity. This allows a computerized generation of results into Normal, Benign, Suspected for Breast Tissue Abnormalities, or Probable for Breast Tissue Abnormalities classifications. Measurable dynamic thermal finger prints (see Science) evidence themselves as much as six years prior to tumor presentation of a size measurable by mammography.

Personalized, Breast Health Now^TM history is available to build a personal history for each person to track their BTA Early Alerts^TM reports. Storage is HIPAA compliant, patient accessible, and available for physician transfer upon patient approval.

The Challenge of Breast Cancer

Breast cancer takes a tremendous toll in the United States. After lung cancer, breast cancer is the second leading cause of death from cancer among women in the United States and is the most common non-skin-related malignancy among U.S. women. Each year, more than 180,000 new cases of invasive breast cancer are diagnosed and more than 40,000 women die from the disease. Until research uncovers a way to prevent breast cancer or to cure all women regardless of when their tumors are found, early detection will be looked upon as the best hope for reducing the burden of this disease.

48M (2009) mammograms conducted annually in U.S., 2M in U.K. with testing every three years. Neither country has many mammograms below age 40. Lawrence Berkeley National Laboratory Life Sciences Division conducted a study detailing the dangers of mammography. “Our work shows that radiation can change the microenvironment of breast cells, and this in turn can allow the growth of abnormal cells with a long-lived phenotype that has a much greater potential to be cancerous,” says Paul Yaswen, a cell biologist and breast cancer research specialist with Berkeley Lab’s Life Sciences Division. View Life Sciences Division Report from Yaswen Lab.